Innovation for development
TNO's Innovation for Development (I4D) program innovates in low- and middle income countries with the aim to improve the lives of 2 billion people living below poverty level (World Bank, 2021). In close collaboration with partners we develop and launch ground-breaking technologies and scale them up with a solid business model. Our inclusive innovations lead to entrepreneurship, employment and sustainable access to affordable services for most vulnerable groups. This is business with impact!
Innovation for sustainable development
Creating prosperity and security for all is of utmost importance. We must respond to high population growth, unemployment of youth, migration flows, climate change, scarcities of food and resources and the consequences of the COVID pandemic. The 2 billion people living below poverty level ($ 3,20 a day) in low- and middle income countries will be affected first. Infrastructure is now stretched beyond limits and innovation is needed to facilitate sustainable development.
To tackle these issues TNO develops technical and social innovations. We work with an extensive network of partners from private sector, government, knowledge institutes, NGO’s and social impact investors in Africa, Asia and Europe. TNO acts as knowledge partner and provides know-how on technology, business models and transition management. If you are interested to join forces; please contact us!
Contributing to sustainable development goals
Although we contribute to 13 out of 17 Sustainable Development Goals (SDGs), our main impact is at the following SDGs:
- SDG 3 – Good health and well being
- SDG 8 – Decent work and economic growth
- SDG 9 – Industry, innovation and infrastructure
- SDG 12 – Responsible consumption and production
Currently, our inclusive innovations improve the lives of 300.000 people with low incomes. Steering on the market demand and pressing issues we focus on 6 propositions for low- and middle income countries.
Stay up to date
Sign up for our newsletter: TNO Innovation for Development.
Mathilde MiedemaFunctie:Programma directeur
Looking for an expert?View all experts
TNO helps accelerate drug development through insight
To find the most effective interventions for complex metabolic diseases, we must first understand the dynamics of disease onset and progression. Only then can key targets and optimal therapeutic windows for more effective treatment be defined. We spoke with Anita van den Hoek, Research Scientist for TNO Metabolic Health, about how TNO helps pharmaceutical companies accelerate drug development through better understanding of disease pathways.
TNO proves method for effective pediatric drug development
Safe and effective drug dosing for young children come with their own challenges. Up to the age of 18, a child’s metabolism can change significantly. And in the first two years of life, those ontogenic differences can be rapid and dramatic. TNO published its findings from the first drug disposition (mass balance/metabolite profiling) study to conclusively prove that microtracing with accelerator mass spectrometry (AMS) is an effective way to collect clinical data in these young patients. This AMS technology can also be the key to building up more data on drug interventions in pregnant and lactating mothers.
Translational models TNO excel in preclinical research
Public Private Partnership Arla Food Ingredients and Danone
International Women’s Day 2022
Today on International Women’s Day we celebrate the success and achievements of women in science for breaking down barriers and challenging the status quo. Get to know some of TNO’s women contributing to a sustainable society every day.